2013
DOI: 10.1111/jth.12051
|View full text |Cite|
|
Sign up to set email alerts
|

Rho GTPases in platelet function

Abstract: Summary The Rho family of GTP binding proteins – also commonly referred to as the Rho GTPases – are master regulators of the platelet cytoskeleton and platelet function. These low molecular weight or “small” GTPases act as signaling switches in the spatial and temporal transduction and amplification of signals from platelet cell surface receptors to the intracellular signaling pathways that drive platelet function. The Rho GTPase family members RhoA, Cdc42 and Rac1 have emerged as key regulators in the dynamic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
155
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 148 publications
(161 citation statements)
references
References 174 publications
5
155
0
1
Order By: Relevance
“…Additionally, mutETV6 platelets showed defects in functions classically associated with CDC42 (i.e., filopodia formation) and RHOA (i.e., lamellipodia formation and clot retraction). 36 EM also showed platelets of variable sizes and having a more circular instead of discoid shape. RNA sequencing previously performed on mutETV6 transfected cells, patient platelets and leukemia cells did not reveal any modification in Rho GTPase mRNA levels, 1,3 which may be due to variations in the models applied.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Additionally, mutETV6 platelets showed defects in functions classically associated with CDC42 (i.e., filopodia formation) and RHOA (i.e., lamellipodia formation and clot retraction). 36 EM also showed platelets of variable sizes and having a more circular instead of discoid shape. RNA sequencing previously performed on mutETV6 transfected cells, patient platelets and leukemia cells did not reveal any modification in Rho GTPase mRNA levels, 1,3 which may be due to variations in the models applied.…”
Section: Discussionmentioning
confidence: 94%
“…36 Therefore, we hypothesize that ETV6 repressive activity is a key regulator of megakaryocyte cytoskeleton remodeling, driven via Rho GTPases in mutETV6 carriers. mutETV6 was associated with a decrease in CDC42 and RHOA expression levels in platelets without affecting RAC1 expression.…”
Section: Discussionmentioning
confidence: 97%
“…In platelets, the actin cytoskeleton is essential for filopodia formation and spreading, 28 and is therefore a likely mediator of spatially regulated a-granule secretion. To determine the role of those, first we examined the effects of pharmacologic cytoskeletal inhibitors of actin polymerization (latrunculin A) and microtubule assembly (nocodazole).…”
Section: Resultsmentioning
confidence: 99%
“…Our data also indicate that, further downstream, Rac1 also mediates platelet mechanosensing of substrate stiffness. In platelets, Rac1 acts downstream of integrin α IIb β 3 outside-in signaling to regulate lamellipodia formation, platelet aggregation, and granule secretion (43,44), and can activate Rap1b, which is involved in inside-out integrin α IIb β 3 activation (45). As Rac1 inhibition decreases platelet adhesion and activation on stiffer gels in a dose-dependent manner, it is likely that this integrin-Rac1-Rap1b circuit provides the mechanosensing machinery during platelet adhesion, further α IIb β 3 activation, and integrin clustering when platelets adhered on stiffer substrates, thus increasing adhesion as substrate stiffness increases.…”
Section: Discussionmentioning
confidence: 99%